143 related articles for article (PubMed ID: 2268214)
21. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.
Carlson JA; Dickersin GR; Sober AJ; Barnhill RL
Cancer; 1995 Jan; 75(2):478-94. PubMed ID: 7812919
[TBL] [Abstract][Full Text] [Related]
22. Desmoplastic malignant melanoma and its variants. A study of 45 cases.
Jain S; Allen PW
Am J Surg Pathol; 1989 May; 13(5):358-73. PubMed ID: 2712188
[TBL] [Abstract][Full Text] [Related]
23. Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy.
Broer PN; Walker ME; Goldberg C; Buonocore S; Braddock DT; Lazova R; Narayan D; Ariyan S
Eur J Surg Oncol; 2013 Jul; 39(7):681-5. PubMed ID: 23522951
[TBL] [Abstract][Full Text] [Related]
24. Neurotropic Melanoma. A variant of desmoplastic melanoma.
Kossard S; Doherty E; Murray E
Arch Dermatol; 1987 Jul; 123(7):907-12. PubMed ID: 3606170
[TBL] [Abstract][Full Text] [Related]
25. The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.
MacKenzie Ross AD; Haydu LE; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Scolyer RA; Thompson JF
Ann Surg Oncol; 2016 Apr; 23(4):1082-9. PubMed ID: 26561405
[TBL] [Abstract][Full Text] [Related]
26. Desmoplastic malignant melanoma. A clinicohistopathologic study of 25 cases.
Egbert B; Kempson R; Sagebiel R
Cancer; 1988 Nov; 62(9):2033-41. PubMed ID: 3167815
[TBL] [Abstract][Full Text] [Related]
27. The role of sentinel lymph node biopsy in the management of head and neck desmoplastic melanoma.
Mohebati A; Ganly I; Busam KJ; Coit D; Kraus DH; Shah JP; Patel SG
Ann Surg Oncol; 2012 Dec; 19(13):4307-13. PubMed ID: 22766985
[TBL] [Abstract][Full Text] [Related]
28. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
[TBL] [Abstract][Full Text] [Related]
29. Evolving treatment strategies in thin cutaneous head and neck melanoma: 1 institution's experience.
Jaber JJ; Clark JI; Muzaffar K; Ruggiero FP; Feustel PJ; Frett MJ; Zender CA
Head Neck; 2011 Jan; 33(1):7-12. PubMed ID: 20848424
[TBL] [Abstract][Full Text] [Related]
30. Intracranial trigeminal nerve metastasis of a desmoplastic neurotropic melanoma: case report.
Hashemi M; Stark A; Hugo H; Mehdorn M
Cent Eur Neurosurg; 2009 May; 70(2):91-4. PubMed ID: 19711263
[TBL] [Abstract][Full Text] [Related]
31. Radiotherapy influences local control in patients with desmoplastic melanoma.
Strom T; Caudell JJ; Han D; Zager JS; Yu D; Cruse CW; Marzban SS; Messina JL; Trotti AM; Sondak VK; Rao NG
Cancer; 2014 May; 120(9):1369-78. PubMed ID: 24142775
[TBL] [Abstract][Full Text] [Related]
32. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
33. Primary mucosal desmoplastic melanoma of the head and neck.
Prasad ML; Patel SG; Busam KJ
Head Neck; 2004 Apr; 26(4):373-7. PubMed ID: 15054741
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Staged Excision With Permanent Section Margin Control for Cutaneous Head and Neck Melanoma.
Moyer JS; Rudy S; Boonstra PS; Kraft C; Chinn SB; Baker SR; Schwartz JL; Bichakjian CK; Fullen D; Durham AB; Lowe L; Johnson TM
JAMA Dermatol; 2017 Mar; 153(3):282-288. PubMed ID: 28002553
[TBL] [Abstract][Full Text] [Related]
35. Cranial neuropathy as a presenting sign of recurrent aggressive skin cancer.
Leach BC; Kulbersh JS; Day TA; Cook J
Dermatol Surg; 2008 Apr; 34(4):483-97. PubMed ID: 18248467
[TBL] [Abstract][Full Text] [Related]
36. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
37. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.
Statius Muller MG; van Leeuwen PA; van Diest PJ; Pijpers R; Nijveldt RJ; Vuylsteke RJ; Meijer S
World J Surg; 2002 Dec; 26(12):1405-11. PubMed ID: 12297910
[TBL] [Abstract][Full Text] [Related]
38. The invasive growth potential of residual melanoma and melanoma in situ.
DeBloom JR; Zitelli JA; Brodland DG
Dermatol Surg; 2010 Aug; 36(8):1251-7. PubMed ID: 20666813
[TBL] [Abstract][Full Text] [Related]
39. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
40. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
